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Summary of background data: Adolescent idiopathic scoliosis can progress and affect the health related quality
of life of the patients. Research shows that screening is effective in early detection, which allows for bracing and
reduced surgical rates, and may save costs, but is still controversial from a health economic perspective.
Study design: Model based cost minimisation analysis using hospital’s costs, administrative data, and market prices
to estimate costs in screening, bracing and surgical treatment. Uncertainty was characterised by deterministic and
probabilistic sensitivity analyses. Time horizon was 6 years from first screening at 11 years of age.
Objective: To compare estimated costs in screening and non-screening scenarios (reduced treatment rates of 90%,
80%, 70% of screening, and non-screening Norway 2012).
Methods: Data was based on screening and treatment costs in primary health care and in hospital care settings.
Participants were 4000, 12-year old children screened in Norway, 115190 children screened in Hong Kong and 112
children treated for scoliosis in Norway in 2012. We assumed equivalent outcome of health related quality of life,
and compared only relative costs in screening and non-screening settings. Incremental cost was defined as positive
when a non-screening scenario was more expensive relative to screening.
Results: Screening per child was € 8.4 (95% CrI 6.6 to10.6), € 10350 (8690 to 12180) per patient braced, and €
45880 (39040 to 55400) per child operated. Incremental cost per child in non-screening scenario of 90% treatment
rate was € 13.3 (1 to 27), increasing from € 1.3 (−8 to 11) to € 27.6 (14 to 44) as surgical rates relative to bracing
increased from 40% to 80%. For the 80% treatment rate non-screening scenario, incremental cost was € 5.5 (−6 to
18) when screening all, and € 11.3 (2 to 22) when screening girls only. For the non-screening Norwegian scenario,
incremental cost per child was € -0.1(−14 to 16). Bracing and surgery were the main cost drivers and contributed
most to uncertainty.
Conclusions: With the assumptions applied in the present study, screening is cost saving when performed in girls
only, and when it leads to reduced treatment rates. Cost of surgery was dominating in non-screening whilst cost of
bracing was dominating in screening. The economic gain of screening increases when it leads to higher rates of
bracing and reduced surgical rates.
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Adolescent idiopathic scoliosis (AIS) is a complex three
dimensional deformity of the spine, characterized by
lateral curvature >10° and axial rotation, which affects
2-3% of otherwise healthy teenagers [1-3]. The deformity
usually progresses with rapid growth of the spine and can
affect health related quality of life of the patients [4]. Con-
ventional treatment options are bracing and surgery
[1-3]. Bracing is normally recommended for progres-
sive curves of 20-40° in immature patients to prevent
progression and reduce surgery, whilst surgery is con-
sidered for curves >45°-50° to stop progression and
correct the deformity [1]. In patients with AIS, only a
minority have progressive curves requiring treatment
[5], and 90% of those treated are girls [6,7]. Treatment
outcomes are usually measured by radiographic changes
of the curves, but increasingly also by changes in health
related quality of life. Early detection by screening
allows for monitoring curve progression, and timely
initiation of bracing. A recent randomised study found
bracing to reduce curves which progress to the threshold
of surgery [5].
Screening is controversial and practices vary worldwide
[8-10]. Opponents cite mainly increased costs and lack of
effectiveness of the programs. Some previous studies
have supported whilst others have discouraged screen-
ing [11,12]. The United States Preventive Services Task
Force neither supported nor opposed screening in 1993
[12,13], but recommended against routine screening in
2004 [14]. Discontinuation of screening programs has
led to late detection and high rates of surgeries in various
countries [15-17]. Currently, most international scoliosis
and child health societies support and recommend screen-
ing [18]. The Scoliosis Research Society’s International
task force recently reported even before the BRAIST study
[5] was published, that screening was effective in tech-
nical, clinical, program, and treatment efficacy, but
could not make a statement on cost effectiveness due
to lack of studies evaluating costs and health economic
analyses [19].
Reviews and long-term studies suggest that health
related quality of life of patients treated with brace
or surgery are not different [1,2,6]. The aim of the
present study was therefore to perform a cost
minimization analysis (CMA) comparing only costs in
screening and non-screening settings, while assuming
equal long term health related quality of life of patients
whose scoliosis are detected through screening or
without.
Methods
We used a model approach to compare costs in screen-
ing with non-screening scenarios. The main mathemat-
ical equation on which the model was based is shown inAdditional file 1. Input model parameters were collected
from screening and hospital care. Screening in Norway
was performed once in 12-year old children, and did not
detect patients suitable for bracing [20]. We assumed
similar epidemiology and natural history of AIS in Hong
Kong and Norway, and used suitable data from a large
population-based cohort longitudinal screening study
by Lee et al. from Hong Kong in 2010 as model input
for screening [21]. In this study, 115190 children were
screened: 3158 received X-rays, 59 had out-patient visits
for further assessment only, 264 were braced, 10 had
surgery, and 29 had both brace and surgery (85% brace
and 15% surgery). The percent treated in Hong Kong
was thus 2.63 per 1000 children.
Screening is no longer performed in Norway. Ac-
cording to administrative data from the three scoliosis
clinics in Norway, 122 adolescents were treated for
scoliosis in 2012, of which 51(42%) were braced and
71(58%) had surgery, with about 10% of them having
both brace and surgery. These 122 children, aged 11
to 17 is the number of patients out of the cohort of
63421 children who were the target group for scoliosis
treatment in Norway for that year. Thus, the percent
of children treated in Norway in 2012 was 1.92 per
1000 children.
Model input for the non-screening scenarios were
based on Norwegian data when available. Otherwise, in-
puts were estimated from the Hong Kong data.
Study perspective in relation to costs
We used a health sector budget perspective focusing on
the costs related to orthopaedic treatment in hospital
care [22], and in addition, we included costs for the soci-
ety due to transportation and parents’ opportunity cost
of time during treatment of their children.
Strategies being compared
Screening for scoliosis may lead to over-referrals to X-rays
and outpatient evaluations, increased rates of bracing, but
reduced surgical rates compared to settings when children
are not screened [23,24]. In non-screening settings, many
children are diagnosed late when they are matured, with
curves not suitable for bracing [15-17,23]. We therefore
assumed that reduced numbers of children are treated for
scoliosis in non-screening settings and estimated reduced
treatment rates of 90%, 80%, and 70%, respectively of
those treated in screening by Lee et al. We compared
costs in these reduced treatment rates to costs in the
screening setting in Hong Kong. Treatment in this context
includes the percentage of children who have X-rays for
diagnosis, those treated with brace or surgery, and those
who have further follow-ups. The estimated treatment rate
of non-screening in Norway 2012 was 73% of that in Hong
Kong. We also compared costs in non-screening scenario
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Hong Kong. Since AIS is more prevalent in girls, and 90%
of those treated for AIS are girls [5,6], we performed
separate analyses in girls.
In all non-screening scenarios, we simulated different
distribution rates of brace and surgery based on the
available non-screening data from Norway (58% surgery
and 42% brace), since this is the only available data on
the distribution of brace and surgery in a non-screening
setting. We used data from Hong Kong to estimate the
frequency of X-ray examination and referrals since
non-screening Norwegian data was not available (see
Additional file 1). Based on this study, we estimated
that about 15% of children required referrals to X-ray
and to specialist’s examinations. In all non-screening
scenarios, these rates were adjusted accordingly.
Incremental cost was defined as the cost of treat-
ment in a non-screening scenario minus the cost of
treatment and cost incurred in conducting the screen-
ing. A positive incremental cost therefore implies that
screening is more cost saving compared to the non-
screening scenario. How incremental cost changes by
varying the ratio of bracing to surgery was estimated
for all the non-screening scenarios. The probability of
the incremental cost being positive was estimated for
all cases.
Time horizon for cost estimations, discount rate
The time horizon for estimating costs was six years from
the first screening at 11 years of age. We assumed two
screenings per child, based on the recommendations of
the Scoliosis Research Society [18] at the age of 11 and
13 years, and anticipated that 60% of the scoliosis cases
were detected at the first screening and the rest at the
second. We based our assumption on the knowledge of
age and gender- specific prevalence of scoliosis, as well
as the length of time between detection and treatment.
Since screening tests are not fully accurate, it has also
been suggested that scoliosis screening programs should
be planned as a continuous process and not just a once
and for all project as there is a possibility of missing out
on some cases if screening is performed only once. For
the non-screening scenarios we also assumed a disper-
sion of the expected cost (bracing and surgery) of 10%,
15%, 20%, 20%, 15% 10%, and 10% for each age group
from 11 to 17 respectively. The literature is scarce with
regards to the true dispersion of expected costs in scoli-
osis treatment, but shows a peak of treatment around
13–14 years of age. We therefore assumed 25% expected
costs before, and 35% after the peak years [2,5,6,25].
When aggregating costs over time, we used an annual
social discount rate of 4% (as recommended by the
Norwegian Directorate of Health [26]) to calculate the
present value of costs. The social discount rate is aninterest rate used to bring future value into the present
when considering the time value of money [22].
Estimating costs and resources
We used hospital’s costs and administrative data, and
market prices to estimate the cost of screening, bracing
and surgery.
Screening
Screening was performed once in 4000 twelve year
old children as part of a vaccine and physical exam-
ination program from autumn 2006 to spring 2007
[20]. Community nurses and physical therapists per-
formed the screening. All activities directly involved
in the screening and follow-up of patients were iden-
tified, measured, and costs estimated (Table 1).
Bracing and surgery
We estimated the costs of bracing and surgery based
on data from hospital records. For bracing, we esti-
mated the costs of the brace equipment, transporta-
tion, radiographic and clinical examinations during
the period of brace wear, 3 days hospital hotel ser-
vices for the child and one parent during brace fit-
ting. Additionally, the costs of reimbursements for
wear and tear of clothing and beddings from the
National Insurance Scheme were included. For sur-
gery, we estimated the costs of implants, salaries of
the staff at the theatre, intensive care, intermediate
postoperative care, regular ward costs, and costs of
re-operations (Table 1).
Surgery was usually performed using either a hybrid
construct with an average of 5 pedicle screws, 8 hooks,
and 5 to 6 sublaminar wires or an all pedicle-screw
construct using 15 to 17 pedicle screws. Two surgeons
usually performed the surgery using an estimated aver-
age time of 180 minutes. One anesthesiologist, one
anesthesiology nurse and two scrub nurses assisted
them working on average for 300 minutes. After sur-
gery, patients stayed in hospital for an average of 10 days.
No braces were used postoperatively. During the first
postoperative year, patients had two follow-up consulta-
tions. In addition, costs of radiological examinations, out-
patient visits for follow-ups, transportation, and costs of
complications and re-operations during the first year were
measured.
With the public universal healthcare system in Norway,
there are no hospital fees for parents when children are
braced or surgically treated. Cost per hour for different
health professionals was estimated by adding social costs
of employment (pension, insurance, sick-leave, and train-
ing) and overhead to the salary (inclusive income tax).
The salary and social costs for hospital staff were esti-
mated using the mean salary at the Oslo University
Table 1 Resource unit used, cost (€) per unit, number of units and the uncertainty interval used for the cost estimation
in the probabilistic sensitivity analysis (PSA)
No. Variables Unit cost
(€)
Range
(±%), cost
Units Range
(±%), units
Screening
1 Examiners (minutes) 47 20 9 20
2 Materials and supplies 0.03 20
3 Scoliometer 1.4 20
For confirmation of scoliosis
4 Transportation to X-ray exam 22 50
5 Radiographs 63 30
For confirmed scoliosis >20°
6 Transport to specialist evaluation 182 50
7 Specialist evaluation 62 30
8 Radiographs 128 30
Brace treatment
9 Boston brace 3020 20 1.5 30
10 Reimbursement for wear and tear of clothes and linen/year 725 20 2 20
11 Hospital hotel, days (child and 1 parent) 212 30 3 30
12 Out-patient consultations 62 30 4 20
13 Physical therapy 55 30 1 20
14 Radiographs 128 30 4 20
15 Time used by one parent (days) 289 30 4 30
16 Transportation 137 50 4 50
Surgery
17 Implants/utilities (per operation) 9390 20
18 Out patients consultations 62 30 4.5 10
19 Surgeons (hours)* 118 30 6 20
20 Anesthesiologists (hours) 118 30 5 20
21 Anesthesiologist nurse (hours) 71 30 5 20
22 Scrub nurses (hours)* 71 30 10 20
23 Intensive care (days) 4190 30 1
24 Postoperative care unit (per day) 1872 30 2 25
25 Regular ward (days) 1541 30 8 25
26 Physical therapy 55 30 10 20
27 Radiology examination 160 30 6 20
28 Time used by one parent (days) 289 30 15 30
29 Taxi from home to school after treatment (days) 63 50 10 50
30 Transportation (days) 104 50 6 30
31 Transportation home after surgery 508 50
*Two surgeons and two scrub nurses were involved in each surgery.
All items in each category of interventions were identified, measured, and costs estimated. Percentage of uncertainty was estimated for each item.
The percentages of the uncertainty of the PSA’s are also given.
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based on data from the Norwegian Central Bureau of
Statistics [27]. Salary and social costs of public health
nurses were based on data from the Norwegian Nurses
organization, and local community administrations.Currency, price date and conversion
All prices and costs were converted from 2006 to 2012
NOK (Norwegian kroner) by using an inflation rate of
3.21% per year based on the yearly rate of change of one
unit value within the Diagnosis-Related Group (DRG)
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NOK =1 € (Euro).
Statistical analysis
Values are given as numbers, percentages, means and
mean differences. Results are presented with a 95% cred-
ibility interval (CrI), which show the 2.5th and 97.5th
percentile of the outcome distribution. The uncertainty
of input variables was assessed by one-way and multi-
way sensitivity analyses. Parametric uncertainty was ana-
lyzed by probabilistic sensitivity analysis (PSA), where all
uncertainties in the relevant parameters were accounted
for simultaneously [22,28]. The PSA was used to analyse
the distribution of incremental cost estimations in all
scenarios (100000 interactions) and to estimate the CrI
for total incremental costs, which forms the basis for the
Tornado diagram in Figure 1. In the PSA, we used
gamma distributions for estimation of unit costs, beta
distributions for the number of hours used and their
probabilities. Poisson distributions were used for the
number of children treated.
The screening study was approved by the Regional
Ethical Committee for Medical Research in Norway.
Results
Cost estimations
For all the relevant scenarios, the total estimated costs
were € 8.4 (95% CrI 6.6 to 10.6) per child screened, €
10350 (8690 to 12180) per patient braced, and € 45880
(38040 to 55400) per surgery (re-operations included).
The average time used to screen a child was 9 minutes
(Table 1).
Incremental costs and outcomes
The incremental cost per child in a non-screening sce-
nario of 90% treatment rate compared with screening
was € 13.3 (1 to 27). The probability of the incremental
cost being positive was 99%. In the 80% treatment rateFigure 1 Tornado diagram (sensitivity analysis) for comparing the 80%non-screening scenario, incremental cost was € 5.5
(−6 to 18) with the probability of the incremental
cost being positive was 82%. When comparing non-
screening scenarios to screening for girls only: the
incremental cost was € 11.3 (2 to 22) for the 80%
treatment rate scenario and € 4.3 (−4 to 14) for the
70% treatment rate scenario. The probability of the
incremental cost being positive was 99% and 82%,
respectively. The incremental cost per child in the
non-screening Norwegian scenario compared with screen-
ing was € 0.1 (−14 to 16), and the probability of the costs
being positive was 50% (Table 2).
Comparing the undiscounted cost per child in the 80%
treatment rate non-screening scenario, to screening, the
cost of bracing per child of € 26.0 (21 to 33) was domin-
ating in the screening scenario, whilst the cost of surgery
per child of € 60.2 (48 to 75) was dominating in the non-
screened scenario.
Incremental cost in the non-screening 90% treatment
rate scenario varied from € -6.3 (−13 to 3) to € 27.6
(14-42) as the percentage of surgery increased from 30%
to 80%. For the 80% treatment rate scenario with 30%
surgery, and 70% bracing, incremental cost was € -11.0
(−19 to −3) favouring non-screening. With 80% surgery,
and 20% bracing, incremental cost was € 18.2 (6 to 33)
favouring screening (Table 3).
Characterizing uncertainty
The expected incremental cost estimates are shown in
Figure 2. In the 90% treatment rate non-screening
scenario, the probability of a positive incremental cost
was close to 100%. Results comparing non-screening
scenarios to screening in girls are shown in Figure 3.
Uncertainty is also illustrated in the tornado diagram for
the non-screening scenario of 80% treatment rate. The
most important contributor to uncertainty was the
percent braced, followed by the probability of being re-
operated (Figure 1).treatment rate of Lee et al. non-screening scenario to screening.
Table 2 Cost (€) per alternative (screening boys and girls combined vs girls only) and incremental cost relative to
screening in four non-screening scenarios with a 95% Credibility Interval (CrI)
Screening boys and girls Screening girls only
Cost per
child
Incremental cost
per child
Probability
incremental cost >0
Cost per
child
Incremental cost
per child
Probability
incremental cost >0
Screening 57.0 (49 to 66) - 50.6 (44 to 58) -
Non-screening Norway 57.1 (44 to 73) 0.1 (−14 to 16) 50% 57.1 (44 to 73) 6.5 (6 to 21) 84%
Non-screening 90% treatment
rate of Lee et al.
70.3 (59 to 84) 13.3 (1 to 27) 99% 70.3 (59 to 85) 18.4 (8 to 30) >99%
Non-screening 80% treatment
rate of Lee et al.
62.5 (52 to 75) 5.5 (−6 to 18) 82% 62.5 (52 to 75) 11.3 (2 to 22) 99%
Non-screening 70% treatment
rate of Lee et al.
54.7 (46 to 66) −2.3 (−13 to 9) 33% 54.7 (46 to 66) 4.3 (−4 to 14) 82%
The incremental cost was highest in the 90% treatment rate non-screening scenario with probability of being > 0 close to 100%. Incremental cost in non-screening
Norway 2012 is close to the 70% treatment rate scenario. Incremental costs were higher in all non-screening scenarios when comparing screening of girls only than
when comparing to screening of both boys and girls. The probabilities of incremental costs being >0 are also higher when comparing non-screening scenarios to
screening of girls only than for both boys and girls combined.
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Scoliosis screening programs are considered to be bene-
ficial from a clinical point of view [19], but are criticized
for high costs due to high referral and treatment rates
[8,11,13]. In the present study we used data from a large
longitudinal screening study, and detailed costing of all
activities in performing the analyses. Results suggest that
screening is cost saving, unless both treatment rates and
surgical rates are very low in comparative non-screening
scenarios. In agreement with previously published stud-
ies reporting that discontinuation of screening has led to
late detection and high rates of surgery [15-17], the
model applied in the present study indicates that costs
increase in non-screening scenarios with high rates of
surgery and lower rates of bracing.
The effectiveness of a screening program thus depends
on the costs involved and the number of cases detected
early that result in bracing and less surgery compared to
a non-screening setting. In a recent clinical trial, bracing
reduced the number of children with curve progression
to the threshold of surgery [5].
The results of the present study show that, screening
has a large potential of cost saving if only girls areTable 3 Incremental costs in non-screening scenarios compar
Ratios of brace/surgery in non-screenin
20/80 30/70 4
Treatment rates in
non-screening scenarios
compared to screening
100% 37.0 (22 to 55) 29.7 (16 to 45) 22.4 (
90% 27.6 (14 to 44) 21.0 (9 to 35) 14.5 (
80% 18.2 (6 to 33) 12.4 (1 to 25) 6.5 (
70% 8.8 (−3 to 22) 3.7 (−7 to 15) - 1.4 (
60% - 0.6 (−11 to 11) - 5.0 (−15 to 5) - 9.3 (
Mean 95% Crl are given for non-screening scenarios with treatment rates from 60%
to 70/30.
Non-screening is more expensive with higher treatment rates and higher surgical ra
treatment rates and higher bracing rates compared to screening.screened. Selective screening of girls is most cost saving
because they constitute about 90% of those treated for
scoliosis. In Table 2, we showed that there is a high
probability of cost saving when only girls are screened
compared to non-screening scenarios with treatment rates
widely ranging from 70% to 100% of those of screening.
Table 3 shows that in the extreme non-screening sce-
nario where treatment rates are approaching those of
screening, screening both boys and girls was not cost
saving. Likewise in the extreme non-screening scenario
where treatment rates were very low approaching 60% of
those treated in screening, non-screening becomes cost
saving. However, these scenarios are the least likely to
occur. In the non-screening scenarios where treatment
levels are 90-100% of those in screening, patients are
probably younger at detection, and likely to be recom-
mended bracing according to guidelines and the results
of the recent RCT study on bracing [5]. This implies that
the ratio of bracing/surgery is likely to be >1 and bracing
will be the dominating treatment option. On the contrary,
when treatment levels in non-screening scenarios are in
the 60% to 70% range of that of screening, patients are
likely to be older and curves too large and not suitable fored with screening
g scenarios
0/60 50/50 60/40 70/30
10 to 36) 15.1 (4 to 27) 7.8 (−2 to 18) -0.5 (−8 to 9)
3 to 27) 7.9 (−2 to 19) 1.3 (−8 to 11) - 5.3 (−13 to 3)
−4 to 18) 0.7 (−9 to 11) - 5.2 (−14 to 4) - 11.0 (−19 to −3)
−11 to 9) - 6.5 (−15 to 3) - 11.6 (−20 to −3) - 16.8 (−24 to −9)
−18 to 0) - 13.7 (−22 to −5) - 18.0 (−26 to −10) - 22.5 (−30 to −15)
to 100% combined with different ratios of bracing to surgery from 20/80
tes compared with screening. Non-screening is less expensive with lower
Figure 2 Incremental cost estimations in four non-screening scenarios compared to screening both boys and girls. Incremental costs
increase from left to right looking at the top of the curves. Incremental cost was lowest in non- screening 70% treatment rate of Lee et al (red),
followed by Norway (purple) 80% treatment rate of Lee et al (blue), and 90% treatment rate of Lee et al (green). Incremental costs were highest
with higher treatment rate non-screening scenarios and lower in low treatment rate non- screening scenarios compared to screening of both
boys and girls. The areas under the curves to the right of zero equals the probabilities of incremental costs being >0.
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ing treatment option (i.e. ratio of brace to surgery likely to
be <1).
In the Hong Kong study, about 15% of those detected
by screening ended up having surgery compared toFigure 3 Incremental cost estimations in four non-screening scenarios
from left to right looking at the top of the curves. Incremental cost was low
by non-screening Norway (purple), the 80% treatment rate of Lee et. al non
non-screening scenario (green) compared to screening girls only. The areas
incremental costs >0 which are considerably higher when comparing non-s
non-screening scenarios to screening of both boys and girls (Figure 2).about 60% in non-screening Norway. Obviously, screening
is not cost saving if the number treated in non-screening
approximates that with screening and the surgical rate is
15%. However, this scenario is very unlikely to occur and
was therefore not included in our analyses.compared to screening of girls only. Incremental costs increase
est (cost saving) in the 70% treatment rate of Lee et al (red), followed
screening scenario (blue), and the 90% treatment rate of Lee et al.
under the curves to the right of zero equals the probabilities of
creening scenarios to screening of girls only than when comparing
Adobor et al. Scoliosis  (2014) 9:21 Page 8 of 10An interesting finding according to Table 3 is that
screening both boys and girls tends to increase costs if the
distribution of brace/surgery is 70/30 or 60/40 in a non-
screening scenario. This scenario is also unlikely to occur.
According to a previous Norwegian study non-screening
scenarios of 30/70 or 40/60 are more likely to occur [15].
Our findings are in agreement with a review [29] on cost
effectiveness of screening that found screening to be cost
effective in one study [30], and recommended screening
only for high-risk groups such as girls at twelve years of
age in order to reduce over-referrals and over-treatment.
However, the most recent review was not able to conclude
whether screening was cost effective or not [31]. None of
the studies cited in these reviews, however, applied recom-
mended health economic evaluation principles [32].
Simulations in the present study suggest that the eco-
nomic gain of screening increases when screening leads
to higher rates of bracing and reduced rates of surgery.
In a previous study, we reported higher rates of bracing
and reduced surgical rates during a period of screening
compared to a period without [15]. Similar findings have
been reported from the Netherlands, Sweden and USA
[23,24,33]. Bracing has been shown to reduce progres-
sion of curves to the threshold of surgery. In the recently
published RCT study on bracing, the success rate was
>70% and about 90% in those with high compliance [5].
Similar results were observed at long-term in a large
Norwegian cohort study [6]. The current evidence of
efficacy of bracing in the short term and good results at
long-term indicates that patients with AIS should be
detected early to allow for bracing. In addition, bracing
avoids the complications of surgery, keeps the spine
mobile, and might have positive long term effects. These
benefits should be considered when interpreting the
results of the present study. There has however been a
lack of enthusiasm for bracing in the past amongst care
providers. This is presumably due to the absence of high
level of evidence of efficacy on bracing, and concerns of
negative psychological impact on the patients. The results
from the recent RCT study [5] on bracing do not however
support this view.
With the assumptions made in the current study,
screening of both boys and girls would neither have in-
creased nor decreased costs compared to the treatment
of AIS in Norway in 2012 where the estimated treatment
rate was 73% compared to screening in Hong Kong, and
58% had surgery. However, selective screening of girls
only would have been cost saving in Norway; as shown
in Table 2 above.
Studies in the past have reported varying costs of
scoliosis screening, and costs of bringing cases detected
on screening to treatment, depending on how costs are
measured [30,34-39]. The cost of screening in the current
study is comparable to similar programs in Europe wheretotal costs were included [34-36]. The estimated cost was
based on two screenings per child, and community nurses
performed the screening in conjunction with a vaccine
program. Transportation costs and salaries of health
professionals would have increased if screening had
been performed in a different and isolated setting and not
by community nurses. The estimated costs of bracing and
surgery are comparable to those reported in the literature
[40]. Many factors may influence the validity of our cost
estimations. Treatment costs are likely to be underesti-
mated in our study as bone grafts and intra-operative
neuromonitoring were not used during surgeries, as
compared with a study from the USA [40]. Our study
perspective was limited to costs related only to expenses
in an orthopedic department. We did not include costs
related to primary health care, paramedics and alterna-
tive costs in relation to referred patients. In addition, we
did not systematically register costs of patients’ out- of-
pocket expenses like transportation in relation to adjuvant
treatment for scoliosis. Though physical therapy and
counseling are not routinely offered to AIS patients in
Norway, it is estimated that 1/3 of the patients use
physiotherapy whilst under brace treatment or postop-
eratively [6,41].
Several input parameters contribute to uncertainties
in our analysis. The cost of regular wards in surgical
treatment was difficult to estimate accurately despite
considerable effort. AIS patients undergoing surgical
treatment require increased nursing resources compared
to caring for ordinary pediatric patients at the orthopedic
ward. The main analyses may also underestimate the cost
of surgery.
The probabilities of positive incremental costs varied
widely in the current study. There was however higher
certainty in the incremental cost estimates when compar-
ing non-screening scenarios to screening of girls only, as
opposed to boys and girls combined. More research is
warranted in order to reduce the uncertainties in future
health economic evaluations of scoliosis treatment.
Limitations and strengths
Ideally, randomised studies or controlled prospective stud-
ies are needed to compare outcome in scoliosis treatment
detected through screening or otherwise. However since
the prevalence of scoliosis is low, it is difficult to include
an adequate study sample even within a large country or
internationally. Clinical trials including utility comparisons
of bracing and surgery in both short and long terms
are lacking. Utility scores may differ in shorter periods
during treatment, for example by wearing a rigid brace,
or postoperatively.
We assumed similar prevalence and natural history of
AIS in Hong Kong and Norway in performing the analysis.
Studies, however, show regional variations in the prevalence
Adobor et al. Scoliosis  (2014) 9:21 Page 9 of 10of AIS, like higher prevalence in girls, but not boys in
higher latitudes than in lower latitudes [42]. However, those
differences could be linked to environmental factors such
as the difference in the onset of menses in different
geographic locations [43], and different cultures and not
related to genetics. It is also likely that mechanisms of
referral may be very different in the two settings, and in
various countries, due to healthcare systems structures
and barriers to access. The presentation of AIS has also
been reported to be linked to socioeconomic status and
race [44]. A recent study however found equal preva-
lence of AIS in 12- year old children in Malaysia and
Norway [20,45].
The main strength of the present work is the application
of current recommended standards for reporting health
economic evaluations in conducting the study [32]. This
gives more transparency and complete reporting of
methods and findings which will facilitate interpretation
and comparison of similar studies. We also used data
from the largest reported longitudinal study of screening
cohorts [21]. Analyses were performed to assess the uncer-
tainties. The percentage detected for bracing, costs of sur-
gery, and re-operations were the major contributors to
uncertainty. More accurate estimates of these factors could
improve the reliability and applicability of future analyses.
Generalisability
The model approach used in the current study could be
employed worldwide with local cost estimate variations.
Our results provide the missing economic evidence for
health policy makers and healthcare providers to consider
reintroduction of scoliosis screening.
In providing health services, policy makers are concerned
about costs in view of limited healthcare resources, whereas
patients and their families value the best treatment option
available independent of costs. At present, there is a gap
in the knowledge of the patient’s preference in choosing
treatment options. In a recently published trial, bracing
was preferred to observation by patients and their families
leading to the interruption of the trial and subsequently
continued as a preference study [5].
Conclusions
Early detection through screening leading to bracing and
fewer surgeries may save costs. Selective screening of
high-risk groups like girls should probably be preferred.
Screening is not likely to increase costs unless both
treatment and surgical rates are very low in comparable
settings where screening is not performed.
Consent
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images.Additional file
Additional file 1: The mathematical model.
Competing interests
None of the authors have received benefits for personal or professional use
from a commercial party related directly or indirectly to the subject of this
manuscript e.g., royalties, stocks, stock options, decision making positions.
Authors’ contributions
RDA, PJ and JIB designed the study. RDA, HS, and JIB were involved in the
collection of the data for the manuscript. PJ and SN collected data and
performed the health economic analysis. PJ built and ran the simulation
model for the study. RDA, PJ, HS, SN and JIB took part in the analysis and
the interpretation of results, drafting and critical review of the manuscript. All
authors have given final approval to the version to be published.
Acknowledgements
The authors wish to acknowledge spine surgeons Roger Sørensen and Rolf
Riise for their support during the research work and preparation of the
manuscript. We also wish to acknowledge Health Region Southern Norway,
the public community nurses, physical therapists, and school children who
took part in the screening program. Authors also acknowledge Kristine
Bratholm, Christina Idsøe, and Arild Holme at the economic department at
the Oslo University Hospital, Rikshospitalet for their contribution towards the
preparation of the manuscript. Authors acknowledge immensely the
contribution of public health nurse Silje Rimeslåtten in preparing the
community nurses for the screening program, and collection of data for the
manuscript.
Author details
1Section for Spine Surgery, Department of Orthopedic Surgery, Oslo
University Hospital-Rikshospitalet, Pb 4950, Nydalen, N-0424 Oslo, Norway.
2Oslo and Akershus University College of Applied Sciences, P. O Box 4, St.
Olavs plass, N-0130 Oslo, Norway. 3School of Economics and Business,
Norwegian University of Life Sciences, P. O. Box 5003, N-1432 Ås, Norway.
4Biomechanic lab, Department of Orthopedic Surgery, Oslo University
Hospital-Rikshospitalet, Pb 4950, Nydalen, N-0424 Oslo, Norway. 5Department
of Physical Medicine and Rehabilitation, Oslo University Hospital and
University of Oslo, Pb 4950, Nydalen, N-0424 Oslo, Norway.
Received: 19 August 2014 Accepted: 18 November 2014
References
1. Asher MA, Burton DC: Adolescent idiopathic scoliosis: natural history and
long term treatment effects. Scoliosis 2006, 1:2.
2. Weinstein SL, Dolan LA, Cheng JC, Danielsson A, Morcuende JA: Adolescent
idiopathic scoliosis. Lancet 2008, 371:1527–1537.
3. Parent S, Newton PO, Wenger DR: Adolescent idiopathic scoliosis:
etiology, anatomy, natural history, and bracing. Instr Course Lect 2005,
54:529–536.
4. Weinstein SL, Dolan LA, Spratt KF, Peterson KK, Spoonamore MJ, Ponseti IV:
Health and function of patients with untreated idiopathic scoliosis - A
50-year natural history study. Jama-J Am Med Assoc 2003, 289:559–567.
5. Weinstein SL, Dolan LA, Wright JG, Dobbs MB: Effects of bracing in
adolescents with idiopathic scoliosis. N Engl J Med 2013, 369:1512–1521.
6. Lange JE, Steen H, Brox JI: Long-term results after Boston brace treatment
in adolescent idiopathic scoliosis. Scoliosis 2009, 4:17.
7. Karachalios T, Sofianos J, Roidis N, Sapkas G, Korres D, Nikolopoulos K: Ten-year
follow-up evaluation of a school screening program for scoliosis. Is the
forward-bending test an accurate diagnostic criterion for the screening of
scoliosis? Spine 1999, 24:2318–2324.
8. Yawn B, Yawn RA: Efficacy of school scoliosis screening. Orthopedics 2001,
24:317.
9. Leaver JM, Alvik A, Warren MD: Prescriptive screening for adolescent
idiopathic scoliosis: a review of the evidence. Int J Epidemiol 1982,
11:101–111.
10. Karachalios T, Roidis N, Papagelopoulos PJ, Karachalios GG: The efficacy of
school screening for scoliosis. Orthopedics 2000, 23:386–391.
Adobor et al. Scoliosis  (2014) 9:21 Page 10 of 1011. Burwell G: The British decision and subsequent events. Spine (Phila Pa
1976) 1988, 13:1192–1194.
12. US Preventive Services Task Force: Screening for adolescent idiopathic
scoliosis: Policy statement. JAMA 1993, 269:2664–2666.
13. US Preventive Services Task Force: Screening for adolescent idiopathic
scoliosis: Review article. JAMA 1993, 269:2667–2672.
14. U.S. Preventive Services Task Force. Screening for Idiopathic Scoliosis in
Adolescents: Recommendation Statement. 2004. http://www.
uspreventiveservicestaskforce.org/3rduspstf/scoliosis/scoliors.htm. 2004.
15. Adobor RD, Riise RB, Sorensen R, Kibsgard TJ, Steen H, Brox JI: Scoliosis
detection, patient characteristics, referral patterns and treatment in the
absence of a screening program in Norway. Scoliosis 2012, 7:18.
16. Ali FM, Edgar M: Detection of adolescent idiopathic scoliosis. Acta Orthop
Belg 2006, 72:184–186.
17. Beausejour M, Roy-Beaudry M, Goulet L, Labelle H: Patient characteristics at
the initial visit to a scoliosis clinic: a cross-sectional study in a community
without school screening. Spine (Phila Pa 1976) 2007, 32:1349–1354.
18. Richards BS, Vitale MG: Screening for idiopathic scoliosis in adolescents.
An information statement. J Bone Joint Surg 2008, 90(1):195–198.
19. Labelle H, Richards SB, De Kleuver M, Grivas TB, Luk KD, Wong HK, Thometz
J, Beausejour M, Turgeon I, Fong DY: Screening for adolescent idiopathic
scoliosis: an information statement by the scoliosis research society
international task force. Scoliosis 2013, 8:17.
20. Adobor RD, Rimeslatten S, Steen H, Brox JI: School screening and point
prevalence of adolescent idiopathic scoliosis in 4000 Norwegian children
aged 12 years. Scoliosis 2011, 6:23.
21. Lee CF, Fong DY, Cheung KM, Cheng JC, Ng BK, Lam TP, Mak KH, Yip PS,
Luk KD: Costs of school scoliosis screening: a large, population-based
study. Spine (Phila Pa 1976) 2010, 35:2266–2272.
22. Drummond MF, Sculpher MJ, Torrance GW, O’Brien BJ, Stoddart GL: Methods
for Economic Evaluation of health Care Programmes. 3rd edition. Oxford (UK):
Oxford Medical Publications; 2005.
23. Bunge EM: Screening for scoliosis: do we have indications for
effectiveness? J Med Screen 2006, 13:29–33.
24. Montgomery F, Willner S: Screening for idiopathic scoliosis. Comparison
of 90 cases shows less surgery by early diagnosis. Acta Orthop Scand
1993, 64:456–458.
25. Lange JE, Steen H, Gunderson R, Brox JI: Long-term results after Boston
brace treatment in late-onset juvenile and adolescent idiopathic scoli-
osis. Scoliosis 2011, 6:18.
26. www.helsedirektoratet.no. Discount rate. 2014. Ref Type: Internet
Communication.
27. Statistical Yearbook of Norway, 1975–85 and 2003–11. Statistics Norway; 2012.
Electronic citation.
28. Briggs AH, Claxton KSM: Decision Modelling for Health Economic Evaluation.
Oxford: Oxford University Press; 2006.
29. Sabirin J, Bakri R, Buang SN, Abdullah AT, Shapie A: School scoliosis
screening programme-a systematic review. Med J Malaysia 2010,
65:261–267.
30. Thilagaratnam S: School-based screening for scoliosis: is it cost-effective?
Singapore Med J 2007, 48:1012–1017.
31. Feldman DE, Beausejour M, Sosa JF, Goulet L, Parent S, Labelle H: Cost
effectiveness of school screening for scoliosis:A systemic review. Int J
Child Adolesc Health 2014, 7:7–13.
32. Husereau D, Drummond M, Petrou S, Carswell C, Moher D, Greenberg D,
Augustovski F, Briggs AH, Mauskopf J, Loder E: Consolidated Health
Economic Evaluation Reporting Standards (CHEERS) statement. Cost Eff
Resour Alloc 2013, 11:6.
33. Yawn BP, Yawn RA, Hodge D, Kurland M, Shaughnessy WJ, Ilstrup D,
Jacobsen SJ: A population-based study of school scoliosis screening.
JAMA 1999, 282:1427–1432.
34. Grivas TB, Vasiliadis ES, Maziotou C, Savvidou OD: The direct cost of
“Thriasio” school screening program. Scoliosis 2007, 2:7.
35. Koukourakis I, Giaourakis G, Kouvidis G, Kivernitakis E, Blazos J, Koukourakis
M: Screening school children for scoliosis on the island of Crete. J Spinal
Disord 1997, 10:527–531.
36. Ugras AA, Yilmaz M, Sungur I, Kaya I, Koyuncu Y, Cetinus ME: Prevalence of
scoliosis and cost-effectiveness of screening in schools in Turkey. J Back
Musculoskelet Rehabil 2010, 23:45–48.
37. Yawn BP, Yawn RA: The estimated cost of school scoliosis screening.
Spine 2000, 25:2387–2391.38. Morais T, Bernier M, Turcotte F: Age- and sex-specific prevalence of scoliosis
and the value of school screening programs. Am J Public Health 1985,
75:1377–1380.
39. Roubal PJ, Freeman DC, Placzek JD: Costs and effectiveness of school
screening. Physiotherapy 1999, 85:259–268.
40. Kamerlink JR, Quirno M, Auerbach JD, Milby AH, Windsor L, Dean L, Dryer
JW, Errico TJ, Lonner BS: Hospital cost analysis of adolescent idiopathic
scoliosis correction surgery in 125 consecutive cases. J Bone Joint Surg
Am 2010, 92:1097–1104.
41. Bjerkreim I, Steen H, Brox JI: Idiopathic scoliosis treated with
Cotrel-Dubousset instrumentation: evaluation 10 years after
surgery. Spine 2007, 32:2103–2110.
42. Grivas TB, Vasiliadis E, Savvidou O, Mouzakis V, Koufopoulos G: Geographic
latitude and prevalence of adolescent idiopathic scoliosis. Stud Health
Technol Inform 2006, 123:84–89.
43. Grivas TB, Vasiliadis E, Mouzakis V, Mihas C, Koufopoulos G: Association
between adolescent idiopathic scoliosis prevalence and age at
menarche in different geographic latitudes. Scoliosis 2006, 1:9.
44. Zavatsky JM, Peters AJ, Nahvi FA, Bharucha NJ, Trobisch PD, Kean KE,
Richard S, Bucello Y, Valdevit A, Lonner BS: Disease severity and treatment
in adolescent idiopathic scoliosis: the impact of race and economic
status. Spine J 2013, Oct 5 [Epub ahead of print]
45. Khindarli T: Prevalence of Scoliosis in Primary School Students in Marang
District, Terengganu. http://www.researchgate.net. 2014. Ref Type: Electronic
Citation.Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color figure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
